A startup company, Heliospect Genomics, is offering to help wealthy couples screen their embryos for IQ using controversial technology that raises questions about the ethics of genetic enhancement. Science correspondent Hannah Devlin tells Madeleine Finlay about the joint investigation into the company by the Guardian and the campaign group Hope Not Hate
US startup charging couples to ‘screen embryos for IQ’
More Stories
Experts warn of mental health risks after rise in magic mushroom use
Esports are booming in Africa – but can its infrastructure keep pace?
Canadian researchers trial nature trick to boost mood in winter